Persistent JAK-STAT pathway activation in malignant and non-malignant cells promotes a pro-inflammatory environment that exacerbates MPN pathology and can further stimulate clonal growth, fibrosis, and vascular events [309, 310]. The gene discussed is SOAT1; the disease is myeloproliferative neoplasm.